Jung Cassie — SEC insider filings

SEC reporting owner CIK 1960154. 14 insider filings on record with FilingPulse; latest filed 2026-09-08.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2023-03-09 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aquestive Therapeutics, Inc. (AQST)Chief Operating Officer14—4 legs · 175,590 sh · $975,90126

Insider filings — Jung Cassie

FiledFormIssuerReported transactionsSource
2026-09-084Aquestive Therapeutics, Inc. (AQST)Option exercise/expiry (X): 4,587 @ $0.96 · Option exercise/expiry (X): 4,587 (derivative) @ $0EDGAR
2026-05-074Aquestive Therapeutics, Inc. (AQST)Tax withholding (F): 72,734 @ $4.18EDGAR
2026-04-134Aquestive Therapeutics, Inc. (AQST)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2026-03-114Aquestive Therapeutics, Inc. (AQST)Grant/award (A): 80,000 @ $0 · Sale (S): 45,791 @ $4.17 · Grant/award (A): 42,500 (derivative) @ $0EDGAR
2025-10-174Aquestive Therapeutics, Inc. (AQST)Option exercise (M): 25,000 @ $3.10 · Sale (S): 67,575 @ $7.01 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2025-09-084Aquestive Therapeutics, Inc. (AQST)Option exercise (M): 25,000 @ $3.15 · Option exercise (M): 25,000 @ $0.71 · Sale (S): 62,180 @ $5 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2025-03-114Aquestive Therapeutics, Inc. (AQST)Grant/award (A): 80,000 @ $0 · Tax withholding (F): 7,361 @ $2.65 · Tax withholding (F): 7,997 @ $2.65 · Tax withholding (F): 2,182 @ $2.54 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-11-274Aquestive Therapeutics, Inc. (AQST)Sale (S): 44 @ $4.87EDGAR
2024-10-024/AAquestive Therapeutics, Inc. (AQST)Tax withholding (F): 14,120 @ $4.88EDGAR
2024-03-124Aquestive Therapeutics, Inc. (AQST)Tax withholding (F): 8,300 @ $4.88 · Tax withholding (F): 1,132 @ $4.88EDGAR
2024-03-114Aquestive Therapeutics, Inc. (AQST)Tax withholding (F): 1,365 @ $0 · Grant/award (A): 101,250 @ $0 · Grant/award (A): 50,625 (derivative) @ $0EDGAR
2023-08-094Aquestive Therapeutics, Inc. (AQST)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2023-05-054Aquestive Therapeutics, Inc. (AQST)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2023-03-094Aquestive Therapeutics, Inc. (AQST)Grant/award (A): 110,000 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1960154 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs